Clinical Trial Update: The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the neuroendocrine effects of pioglitazone in patients with lung cancer and cancer cachexia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia
• Lung Cancer

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING